-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$14.50-1.36% Downside
Amryt Pharma plc Frequently Asked Questions
-
What analysts cover Amryt Pharma plc?
Amryt Pharma plc has been rated by research analysts at Leerink Partners in the past 90 days.